ref=new Array();
ref[1] = "Aas K. What makes an allergen an allergen. Allergy 1978; 33: 3-14";
ref[2] = "Baer H . Problems in the standardization of allergenic extracts in the U.S.. In: Regulatory Control and Standardization of Allergenic Extracts. Kurth R, Hrsg. Stuttgart, New York: Gustav Fischer Verlag 1988; 9-13";
ref[3] = "Platts-Mills TAE. Discussion. In: Regulatory Control and Standardization of Allergenic Extracts. Kurth R, Hrsg. Stuttgart, New York : Gustav Fischer Verlag 1988; 141";
ref[4] = "Lehrer S, Reese G. Natural extracts: Do they have a future in allergy diagnosis and therapy? In: Regulatory Control and Standardization of Allergenic Extracts. Kurth R, Hrsg. Stuttgart, New York : Gustav Fischer Verlag 1997; 73-9";
ref[5] = "Björksten F, Halmepuro L. Apple as an allergen source material. In: Regulatory Control and Standardization of Allergenic Extracts.Schaeffer M, Sisk C, Brede HD , Hrsg. Stuttgart, New York : Gustav Fischer Verlag 1987; 279-284";
ref[6] = "Esch RE. Role of proteases on the stability of allergens in extracts. In: Regulatory Control and Standardization of Allergenic Extracts. Kurth R, Hrsg. Stuttgart, New York : Gustav Fischer Verlag 1992; 172-9";
ref[7] = "Becker W-M. Reactivities of immunoglobulin E and immunoglobulin G subclasses identified by isoelectric focusing-immunoprint in allergic patients. Electrophoresis 1989; 10: 633-40";
ref[8] = "Peltre G, Lapeyre J, David B. Heterogeneity of grass pollen allergens(Dactylis glomerata) recognized by IgE antibodies in human patients´ sera by a new nitrocellulose immunoprint technique. Immunol. Letters 1982; 5: 127-31";
ref[9] = "Marsh DG, King L, Løwenstein H, Platts-Mills TAE. Allergen nomenclature. Bull. WHO 1986; 64: 767-70";
ref[10] = "Ferreira F, Hirthenlehner K, Briza P, Breiteneder H, Scheiner O, Kraft D, Breitenbach M, Ebener C. Isoforms of atopic allergens with reduced allergenicity: possible use for specific immunotherapy. Int Arch Allergy Immunol 1997; 113: 125-7";
ref[11] = "Ansari AA, Shenbagamuthri P, Marsh D.Complete Amino acid sequence of Lolium perenne (perennial reye grass) pollen allergen Lop p II. J Biol Chem1989; 264: 11181-85";
ref[12] = "Schramm G, Bufe A, Petersen A, Haas H, Schlaak M, Becker WM. Mapping of IgE binding epitopes on the recombinant major group I allergen of velvet grass pollen, rHol. J Allergy Clin Immunol 1997; 99: 781-7";
ref[13] = "Ebner C, Szépfalusi Z, Ferreira F, Jilik A, Valenta R, Paronchi P, Maggi E, Romagnani S, Scheiner O, Kraft D. Identification of multiple T cell epitopes of Bet v I, the major birch pollen allergen, using specific T-cells. J Immunol 1993; 150: 1047-54";
ref[14] = "Rohac M, Birkner T, Reimnitzer I, Bohle B, Steiner R, Breitenbach M, Kraft D, Scheiner O, Gabl F, Rumpold H . The immunological relationship of epitopes on major tree pollen allergens. Mol Immunol 1991; 28: 897-906";
ref[15] = "Gajhede M, Osmark P, Poulsen FM, Ipsen H, Larsen JN, van Neeren RJJ, Schou C, Løwenstein H, SpangfortMD. X-ray and NMR structure of Bet v 1, the origin of birch pollen allergy. Nature Struct Biol 1996; 3: 1040-5";
ref[16] = "Bufe A, Spangfort MD, Kahlert K, Schlaak M, Becker W-M. Major birch pollen Bet v 1 shows ribonuclease activity. PLANTA 1996;199: 413-5";
ref[17] = "Valenta R, Breiteneder H, Pettenburger K , Breitenbach M, Rumpold H, Kraft D, Scheiner O. Homology of the major birch pollen Allergen, Bet v 1, with the major pollen allergens of alder, hazel, and hornbeam at the nucleic acid level as determind by cross-hybridization. J Allergy Clin Immunol 1991; 87: 677-82";
ref[18] = "Valenta R, Duchene, Ebner C. Valent P, Sillaber C, Deviller P, Ferreira F, Tejkl M, Edelmann H, Kraft D, Scheiner O.Profilins constitute a novel family of functional plant pan-allergens. J Exp Med1992; 175: 377-385";
ref[19] = "Seiberler S, Scheiner O, Kraft D, Lonsdale D, Valenta R. Characterization of a birch pollen allergen, Bet v III, representing a novel class of Ca2+ binding proteins: specific expression in mature pollen and dependence of patients´ IgE binding on protein-bound Ca2+ . EMBO J 1994; 13: 3481-6";
ref[20] = "Villalba M, Batanero E, Lopez-Otin C, Sanchez LM, Monsalve RI, Gonzalez de la Pena MA, Lahoz C, Rodriguez R. The amino acid sequence of Ole e I, the major allergen from olive tree (Olea europea) pollen. Eur J Biochem 1993; 216: 863- 9";
ref[21] = "Petersen A, Schramm G, Becker W-M, Schlaak, M. Comparision of four grass pollen species concerning their grass group V allergens by 2D immunoblotting and microsequencing. Biol Chem Hoppe Seyler 1993; 374: 855-61";
ref[22] = "Petersen A, Becker W-M, Schlaak M. Characterization of grass group I allergens in timothy grass pollen. J. Allergy Clin Immunol 1993; 92: 789-96";
ref[23] = "Grobe K. Gruppe I-Allergenen aus Gräsern sind neuartige Cystein¬proteinasen: Implikationen für Allergenität und Bedeutung für die Pflanze. Dissertation, Universität Hamburg Fachbereich Biologie 1998";
ref[24] = "Petersen A, Schramm G, Schlaak M, Becker WM. Post-translational modifications influence IgE reactivity to the major grass pollen allergen Phl p 1 of timothy grass pollen. Clin Exp Allergy 1998; 28: 315-21";
ref[25] = "Fahlbusch B, Müller W, Diener C, Jäger L. Detection of cross reactive determinants in grass pollen extracts using monoclonal antibodies against group IV and group V allergens. Clin Exp Allergy 1993; 23: 51-60";
ref[26] = "Petersen A, Becker W-M, Schlaak M. Structural investigations of isoforms of the major allergen Phl p V by fingerprinting and microsequencing. Clin Exp Allergy 1994; 24: 250-6";
ref[27] = "Bufe A, Schramm G, Keown MB, Schlaak M, Becker W-M. Major allergen Phl p Vb in timothy grass is a novel pollen RNase. FEBS Letters 1995; 363: 6-12";
ref[28] = "Schramm G, Petersen A, Bufe A, Schlaak M, and Becker W-M. Identification and characterization of the major allergens of velvet grass (Holcus lanatus), Hol l 1 and Hol l 5. Int. Arch. Allergy Immunol. 1996; 110: 354-63";
ref[29] = "Petersen A, Bufe A, Schlaak M, Becker W-M. Characterization on the major allergen group VI in timothy grass pollen (Phl p 6). I. Immunological and biochemical studies. Int Arch Allergy Immunol 1995; 108: 49-54";
ref[30] = "Hausen BM, Vieluf IK. Allergiepflanzen-Pflanzenallergene. München, ecomed 1998: 394-6";
ref[31] = "Platts-Mills TAE. The biological role of allergy. In Allergy: An International Textbook. Lessof MH, Lee TH, Kemmeny DM, Hrsg. Chichester, New York, Brisbane, Toronto, Singapore: John Wiley&Sons 1987; 1-37";
ref[32] = "Oreste U, Coscia MR, Scotto d´Abusco A, Santonastaso V, Ruffilli A. Purification and characterization of Par o I , major allergen of Parietaria officinale. Int Arch Allergy Apll Immunol 1991; 96: 19-27";
ref[33] = "Baldo BA, Donovan GR. House dust mite (Dermatophagoides spp.) Allergens: Research Directions Priorities in the 1990s. In Monographs in Allergy 28: Molecular approaches to the study of allergens. Baldo BA Hrsg. Basel: Karger 1990; 138-58";
ref[34] = "Thomas WR, Smith W, Hales BJ, Carter, MD. Functional Effects of polymorphisms of house dust mite allergens. In Arch Allergy Immunol 1997b; 113: 96-8";
ref[35] = "Thomas WR, Smith W, Hales BJ, Carter, MD, Bennet BJ, Shen H-D, Tovey ER, Chuan KY. Recombinant house dust mite allergens.In: Regulatory Control and Standardization of Allergenic Extracts. Kurth R, Hrg. Stuttgart, New York : Gustav Fischer Verlag 1997a; 87-96";
ref[36] = "Varela J, Ventas P, Carreira J, Barbas JA Gimenez-Gallego G, Polo F. Primary structure of Lep d 1, the main Lepidoglyphus destructor allergen. Eur J Biochem 1994; 225: 93-8";
ref[37] = "Schou C. Animal Allergens. In Allergy and Allergic diseases. Kay AB Hrsg. Oxford: Blackwell science1997; 900-908";
ref[38] = "Morgenstern JP, Griffith IJ, Brauer AW, Rogers BL, Bond JF, Chapman MD, Kuo MC. Amino acid sequence of Fel d 1 , the major allergen of the domestic cat: protein sequence analysis and cDNA cloning. Proc Nat Acad Sci USA 1991; 88: 9690-4";
ref[39] = "Spitzauer S, Schweiger C, Sperr WR, Pandjaitan B, Valent P, Muhl S, Ebener C, Scheiner O, Kraft D, Rumpolld H, Valenta R.Molecular characerization of dog albumin as a cross reactive allergen. J Allergy Clin Immunol 1994; 93: 614-27";
ref[40] = "Trompelt J, Becker W-M, Schlaak M. Analysis of IgG-subclass- and IgE-response in allergic diseases caused by Aspergillus fumigatus by immunoblotting techniques. Int Arch Allergy Immunol 1994; 104: 390-8";
ref[41] = "Crameri R. Recombinant Aspergillus fumigatus allergens: from the nucleotide sequences to clinical applications. Int Arch Allergy Immunol 1998; 115: 99-114";
ref[42] = "Crameri R, SutterM. Display of biologically active proteins of the surface of filametous phages: a cDNA cloning system for selection of functinonal gene products linked to the genetic information responsible for their production. Gene 1993; 137: 69-75";
ref[43] = "Achatz G, Oberkofler H, Lechenauer E, Simon B, Unger A, Kandler D, Ebner C, Prillinger H, Kraft D, Breitenbach M. Molecular cloning of major and minor allergens of Alternaria alternata and Cladosporium herbarum. Mol Immunol 1995; 32: 213-27";
ref[44] = "Arnstein HRV, Cox RA. Protein biosynthesis. In focus. Rickwood D Hrsg. Oxford, New York, Tokyo: IRL Press at Oxford University Press 1992";
ref[45] = "Glover MD, Hames BD. DNA cloning 2, Expression systems: a practical approach. Hrg. Oxford, New York, Tokyo: IRL Press at Oxford University Press 1994";
ref[46] = "Schramm G, Kahlert H, Suck R, Weber B, Stüwe HTh, Müller WD, Bufe A, Becker W-M, Schlaak M, Cromwell O, Fiebig H. Mutant-forms of the grass pollen allergen rPhl p 5b have reduced IgE-reactivity but retain T-cell reactivity. J Allergy Clin Immunol 1997; Suppl 4: 35";
ref[47] = "Slater JE, Colberg-Poley A. A DNA Vaccine for Allergen Immunotherapy using the latex allergen Hev b 5. In: Regulatory Control and Standardization of Allergenic Extracts. Kurth R, Hrsg. Stuttgart, New York : Gustav Fischer Verlag 1997; 230-6";
ref[48] = "Elsayed S, Bennich H. The primary structure of allergen M from cod. Scand J Immunol 1975; 4: 203-8";
ref[49] = "Frohne D, Jensen U. Systematik des Pflanzenreichs: unter besonderer Berücksichtigung chemischer Merkmale und pflanzlicher Drogen. 4. Auflage, Gustav Fischer Verlag 1992, Stuttgart, Jena New York";
ref[50] = "Grampp EG. Beeinflussung von Lebensmitteltechnologien, des Genußwertes und des Nährwertes bestimmter Lebensmittel durch Enzyme. Ernährungs-Umschau 27:9-15 (1980)";
ref[51] = "Klimek L. Die immunregulative Wirkung zellulärer Rezeptormoleküle am Beispiel des HLA - II - Rezeptors in der Nahrungsmittelallergie. Allergologie, 15:5 (1992) 176 - 179";
ref[52] = "Klimek L, Mösges R, Schnitzler N, Bartsch M. HLA Antigens in food allergy with rhinological symptoms. J Allergy Clin Immunol 4 (1992) 335 - 337";
ref[53] = "Morgenstern J, Griffith I, Bauer A et al. Determination of the amino acid sequence of Fel d I, the major allergen of the domestic cat: protein sequence analysis and DNA cloning. Proc Nat Acad Sci 88 (1991) 9690";
ref[54] = "Reed G, Rehm HJ (Hrsg.) Food and feed production with microorganisms. Biotechnology Vol. 5 Verlag Chemie, Weinheim 1983.";
ref[55] = "Strasburger E, Lehrbuch der Botanik für Hochschulen. 33. Auflage, neubearbeitet von P Sitte, Gustav Fischer Verlag 1991, Stuttgart, Jena, New York";
ref[56] = "Bousquet J, Van CP, Khaltaev N (2001) Allergic rhinitis and its impact on asthma. J Allergy Clin Immunol 108:S147-S334";
ref[57] = "Pariente PD, LePen C, Los F, Bousquet J (1997) Quality-of-life outcomes and the use of antihistamines in a French national population-based sample of patients with perennial rhinitis. Pharmacoeconomics 12:585-595";
ref[58] = "Ring J, Wenning J (2000) Weißbuch: Allergie in Deutschland 2000. Deutsche Gesellschaft für Allergie und klinische Immunologie. Urban und Vogel, München";
ref[59] = "Statistisches Bundesamt (2000) Gesundheitsbericht für Deutschland. Spezialbericht Allergien. Metzler-Poeschel, Stuttgart";
ref[60] = "Virchow JC (2008) Eine Studie über die Krankheitsbelastung der allergische Rhinitis in Deutschland. Allergologie, Manuskript zur Publikation eingereicht";
ref[61] = "Klimek L, Reichenbach M, Mewes T, Mann W (1997) Untersuchungen zur Reproduzierbarkeit und jahreszeitlichen Abhängigkeit von spezifischen intranasalen Provokationstests bei Birkenpollenallergikern. Laryngorhinootologie 76:475-479";
ref[62] = "Connell JT (1969) Quantitative intranasal pollen challenges. 3. The priming effect in allergic rhinitis. J Allergy 43:33-44";
ref[63] = "Ciprandi G, Buscaglia S, Pesce G, Pronzato C, Ricca V, Parmiani S, Bagnasco M, Canonica GW (1995) Minimal persistent inflammation is present at mucosal level in patients with asymptomatic rhinitis and mite allergy. J Allergy Clin Immunol 96:971-979";
ref[64] = "Kripke ML, Munn CG, Jeevan A, Tang JM, Bucana C (1990) Evidence that cutaneous antigen-presenting cells migrate to regional lymph nodes during contact sensitization. J Immunol 145:2833-2838";
ref[65] = "Picker LJ (1994) Control of lymphocyte homing. Curr Opin Immunol 6:394-406";
ref[66] = "Johnson JG, Jenkins MK (1992) Co-stimulatory functions of antigen-presenting cells. J Invest Dermatol 99:62S-65S";
ref[67] = "Mosmann TR, Cherwinski H, Bond MW, Giedlin MA, Coffman RL (2005) Two types of murine helper T cell clone. I. Definition according to profiles of lymphokine activities and secreted proteins. 1986. J Immunol 175:5-14";
ref[68] = "Maggi E, Parronchi P, Manetti R, Simonelli C, Piccinni MP, Rugiu FS, De CM, Ricci M, Romagnani S (1992) Reciprocal regulatory effects of IFN-gamma and IL-4 on the in vitro development of human Th1 and Th2 clones. J Immunol 148:2142-2147";
ref[69] = "Modlin RL (1994) Th1-Th2 paradigm: insights from leprosy. J Invest Dermatol 102:828-832";
ref[70] = "Jones HE, Inouye JC, McGerity JL, Lewis CW (1975) Atopic disease and serum immunoglobulin-E. Br J Dermatol 92:17-25";
ref[71] = "Enk AH, Katz SI (1992) Identification and induction of keratinocyte-derived IL-10. J Immunol 149:92-95";
ref[72] = "Vercelli D (1993) Regulation of IgE synthesis. Allergy Proc 14:413-416";
ref[73] = "van Reijsen FC, Bruijnzeel-Koomen CA, Kalthoff FS, Maggi E, Romagnani S, Westland JK, Mudde GC (1992) Skin-derived aeroallergen-specific T-cell clones of Th2 phenotype in patients with atopic dermatitis. J Allergy Clin Immunol 90:184-193";
ref[74] = "Kay AB, Ying S, Varney V, Gaga M, Durham SR, Moqbel R, Wardlaw AJ, Hamid Q (1991) Messenger RNA expression of the cytokine gene cluster, interleukin 3 (IL-3), IL-4, IL-5, and granulocyte/macrophage colony-stimulating factor, in allergen-induced late-phase cutaneous reactions in atopic subjects. J Exp Med 173:775-778";
ref[75] = "Schartz L, Huff T (1993) Biology of mast cells and Basophils. In: Middleton Ej, Reed CE, Ellis EF (eds) Allergy, Principles and Practice. Mosby-Year-Book, St. Louis,";
ref[76] = "Church MK, el-Lati S, Caulfield JP (1991) Neuropeptide-induced secretion from human skin mast cells. Int Arch Allergy Appl Immunol 94:310-318";
ref[77] = "Naclerio R (2008) Intranasal Corticosteroids reduce occular symptoms associated with allergic rhinitis. Otolaryngology Head Neck Surg 138 (2): 129-139";
ref[78] = "Wardlaw AJ, Moqbel R, Cromwell O, Kay AB (1986) Platelet-activating factor. A potent chemotactic and chemokinetic factor for human eosinophils. J Clin Invest 78:1701-1706";
ref[79] = "Wang JM, Rambaldi A, Biondi A, Chen ZG, Sanderson CJ, Mantovani A (1989) Recombinant human interleukin 5 is a selective eosinophil chemoattractant. Eur J Immunol 19:701-705";
ref[80] = "Schleimer RP, Sterbinsky SA, Kaiser J, Bickel CA, Klunk DA, Tomioka K, Newman W, Luscinskas FW, Gimbrone MA, Jr., McIntyre BW, . (1992) IL-4 induces adherence of human eosinophils and basophils but not neutrophils to endothelium. Association with expression of VCAM-1. J Immunol 148:1086-1092";
ref[81] = "Skoner DP (2001) Allergic rhinitis: definition, epidemiology, pathophysiology, detection, and diagnosis. J Allergy Clin Immunol 108:S2-S8";
ref[82] = "Craig TJ, Teets S, Lehman EB, Chinchilli VM, Zwillich C (1998) Nasal congestion secondary to allergic rhinitis as a cause of sleep disturbance and daytime fatigue and the response to topical nasal corticosteroids. J Allergy Clin Immunol 101:633-637";
ref[83] = "Vuurman EF, van Veggel LM, Uiterwijk MM, Leutner D, O'Hanlon JF (1993) Seasonal allergic rhinitis and antihistamine effects on children's learning. Ann Allergy 71:121-126";
ref[84] = "Lack G (2001) Pediatric allergic rhinitis and comorbid disorders. J Allergy Clin Immunol 108:S9-15";
ref[85] = "Wright AL, Holberg CJ, Martinez FD, Halonen M, Morgan W, Taussig LM (1994) Epidemiology of physician-diagnosed allergic rhinitis in childhood. Pediatrics 94:895-901";
ref[86] = "Leynaert B, Bousquet J, Neukirch C, Liard R, Neukirch F (1999) Perennial rhinitis: An independent risk factor for asthma in nonatopic subjects: results from the European Community Respiratory Health Survey. J Allergy Clin Immunol 104:301-304";
ref[87] = "Ruoppi P, Seppa J, Nuutinen J (1993) Acute frontal sinusitis: etiological factors and treatment outcome. Acta Otolaryngol 113:201-205";
ref[88] = "Keith PK, Conway M, Evans S, Wong DA, Jordana G, Pengelly D, Dolovich J (1994) Nasal polyps: effects of seasonal allergen exposure. J Allergy Clin Immunol 93:567-574";
ref[89] = "Bachert C, Hormann K, Mosges R, Rasp G, Riechelmann H, Muller R, Luckhaupt H, Stuck BA, Rudack C (2003) An update on the diagnosis and treatment of sinusitis and nasal polyposis. Allergy 58:176-191";
ref[90] = "Corey JP, Adham RE, Abbass AH, Seligman I (1994) The role of IgE-mediated hypersensitivity in otitis media with effusion. Am J Otolaryngol 15:138-144";
ref[91] = "McColley SA, Carroll JL, Curtis S, Loughlin GM, Sampson HA (1997) High prevalence of allergic sensitization in children with habitual snoring and obstructive sleep apnea. Chest 111:170-173";
ref[92] = "von ME, Martinez FD, Fritzsch C, Nicolai T, Roell G, Thiemann HH (1994) Prevalence of asthma and atopy in two areas of West and East Germany. Am J Respir Crit Care Med 149:358-364";
ref[93] = "von ME (1997) Epidemiologie des Asthma bronchiale im Kindesalter. Pneumologie 51:949-961";
ref[94] = "Martinez FD, Wright AL, Taussig LM, Holberg CJ, Halonen M, Morgan WJ (1995) Asthma and wheezing in the first six years of life. The Group Health Medical Associates. N Engl J Med 332:133-138";
ref[95] = "Martinez FD (1994) Role of viral infections in the inception of asthma and allergies during childhood: could they be protective? Thorax 49:1189-1191";
ref[96] = "(1995) Childhood asthma and other weezing disorders. Chapman & Hall Medical,";
ref[97] = "von ME (1999) Air pollution and asthma. Immunotherapy in Asthma. Marcel Dekker Ltd,";
ref[98] = "(1991) Health effects of atmospheric acids and their precursors. Report of the ATS workshop on the Health Effects of Atmospheric Acids and their Precursors. Am Rev Respir Dis 144:464-467";
ref[99] = "Committee Of The Environmental And Occupational Health Assembly Of The American Thoracic Society (ATS) (1996) Health effects of outdoor air pollution, Part 1. Am J Respir Crit Care Med 153:3-50";
ref[100] = "Delacourt C, Labbe D, Vassault A, Brunet-Langot D, de BJ, Scheinmann P (1994) Sensitization to inhalant allergens in wheezing infants is predictive of the development of infantile asthma. Allergy 49:843-847";
ref[101] = "Hosoi J, Murphy GF, Egan CL, Lerner EA, Grabbe S, Asahina A, Granstein RD (1993) Regulation of Langerhans cell function by nerves containing calcitonin gene-related peptide. Nature 363:159-163";
ref[102] = "Wiesner-Menzel L, Schulz B, Vakilzadeh F, Czarnetzki BM (1981) Electron microscopical evidence for a direct contact between nerve fibres and mast cells. Acta Derm Venereol 61:465-469";
ref[103] = "Stingl G, Katz SI, Clement L, Green I, Shevach EM (1978) Immunologic functions of Ia-bearing epidermal Langerhans cells. J Immunol 121:2005-2013";
ref[104] = "Inaba K, Schuler G, Witmer MD, Valinksy J, Atassi B, Steinman RM (1986) Immunologic properties of purified epidermal Langerhans cells. Distinct requirements for stimulation of unprimed and sensitized T lymphocytes. J Exp Med 164:605-613";
ref[105] = "Robertson I, Greaves MW (1978) Responses of human skin blood vessels to synthetic histamine analogues. Br J Clin Pharmacol 5:319-322";
ref[106] = "Smith JS, Mansfield LE, de Shazo R, Nelson HS (1980) An evaluation of the pharmacologic inhibition of the immediate and late cutaneous effect to allergen. J Allergy Clin Immunol 65:188";
ref[107] = "Rietschel RL, Fowler JFJr (1995) Fisher's Contact Dermatitis. Williams and Wilkin, Baltimore";
ref[108] = "Lockey RF, Benedict LM, Turkeltaub PC, Bukantz SC (1987) Fatalities from immunotherapy (IT) and skin testing (ST). J Allergy Clin Immunol 79:660-677";
ref[109] = "(1990) The waiting period after allergen skin testing and immunotherapy. American Academy of Allergy and Immunology. J Allergy Clin Immunol 85:526-527";
ref[110] = "Pepys J (1975) Skin testing. Br J Hosp Med 14:412";
ref[111] = "Brown HM, Su S, Thantrey N (1981) Prick testing for allergens standardized by using a precision needle. Clin Allergy 11:95-98";
ref[112] = "Osterballe O, Weeke B (1979) A new lancet for skin prick testing. Allergy 34:209-212";
ref[113] = "Dreborg S (1988) Food allergy in pollen-sensitive patients. Ann Allergy 61:41-46";
ref[114] = "Dreborg S, Backman A, Basomba A (1989) Skin tests used in type I allergy testing. Position paper of the European Academy of Allergy and Clinical Immunology. Allergy 44:1";
ref[115] = "Mantoux C (1908) Intradermoréaction de la tuberculose. Cr Acad Sci 147:355";
ref[116] = "Chipps BE, Talamo RC, Mellits ED, Valentine MD (1978) Immediate (IgE-mediated) skin testing in the diagnosis of allergic disease. Ann Allergy 41:211-215";
ref[117] = "Voorhorst R (1980) Perfection of skin testing technique. A review. Allergy 35:247-250";
ref[118] = "Aas K, Belin L (1974) Acta Allergol 29:238";
ref[119] = "Skassa-Brociek W, Manderscheid JC, Michel FB, Bousquet J (1987) Skin test reactivity to histamine from infancy to old age. J Allergy Clin Immunol 80:711-716";
ref[120] = "Bernstein IL (1988) Proceeding of the task force of guidelines for standardizing old and new technologies used for the diagnosis and treatment of allergic diseases. J Allergy Clin Immunol 82:487";
ref[121] = "Bousquet J (1988) In vivo methods for study of allergy: skin tests. In: Middleton Ej, Reed CE, Ellis EF (eds) Allergy, Principles and Practice. Mosby-Year-Book, St. Louis,";
ref[122] = "LINDBLAD JH, FARR RS (1961) The incidence of positive intradermal reactions and the demonstration of skin sensitizing antibody to extracts of ragweed and dust in humans without history of rhinitis or asthma. J Allergy 32:392-401";
ref[123] = "Hagy GW, Settipane GA (1976) Risk factors for developing asthma and allergic rhinitis. A 7-year follow-up study of college students. J Allergy Clin Immunol 58:330-336";
ref[124] = "Holgate AT, Church MK (1993) Allergy. Gower Medical Publishing, London, New York";
ref[125] = "Leynadier F, Sansarricq M, Didier JM, Dry J (1987) Prick tests in the diagnosis of anaphylaxis to general anaesthetics. Br J Anaesth 59:683-689";
ref[126] = "(1990) Workshop on experimental methodology for clinical studies of adverse reactions to foods and food additives. J Allergy Clin Immunol 86:421-442";
ref[127] = "Sutton BJ, Gould HJ (1993) The human IgE network. Nature 366:421-428";
ref[128] = "Kulig M, Tacke U, Forster J, Edenharter G, Bergmann R, Lau S, Wahn V, Zepp F, Wahn U (1999) Serum IgE levels during the first 6 years of life. J Pediatr 134:453-458";
ref[129] = "Holford-Strevens V, Warren P, Wong C, Manfreda J (1984) Serum total immunoglobulin E levels in Canadian adults. J Allergy Clin Immunol 73:516-522";
ref[130] = "Sitzmann F (1986) Normalwerte. Hans Marseille Verlag, München";
ref[131] = "Mensing H (1994) Zur Differentialdiagnose der Dermatitis atopica. Allergologie 17:477-480";
ref[132] = "Rothenberg ME (1998) Eosinophilia. N Engl J Med 338:1592-1600";
ref[133] = "Burney P, Malmberg E, Chinn S, Jarvis D, Luczynska C, Lai E (1997) The distribution of total and specific serum IgE in the European Community Respiratory Health Survey. J Allergy Clin Immunol 99:314-322";
ref[134] = "Bergmann RL, Edenharter G, Bergmann KE, Guggenmoos-Holzmann I, Forster J, Bauer CP, Wahn V, Zepp F, Wahn U (1997) Predictability of early atopy by cord blood-IgE and parental history. Clin Exp Allergy 27:752-760";
ref[135] = "Wahn V (1998) Differentialdiagnose kindlicher Immundefekte. Prädiat Prax 55:79-100";
ref[136] = "Boccagni P, Favari F, Zanoni G, Pezzini A, Tridente G (1994) Comparison of four in vitro assays for specific IgE detection. Int J Clin Lab Res 24:102-105";
ref[137] = "Bjorksten B (1996) Immunological outcome measures. Eur Respir J Suppl 21:22s-27s";
ref[138] = "Boluda L, Fernandez-Caldas E, Berrens L (1997) The role of IgG in type-I allergy: an unsolved problem. J Investig Allergol Clin Immunol 7:205-210";
ref[139] = "Galli SJ (2000) Mast cells and basophils. Curr Opin Hematol 7:32-39";
ref[140] = "Hammar E, Berglund A, Hedin A, Norrman A, Rustas K, Ytterstrom U, Akerblom E (1990) An immunoassay for histamine based on monoclonal antibodies. J Immunol Methods 128:51-58";
ref[141] = "Brockow K, Vieluf D, Puschel K, Grosch J, Ring J (1999) Increased postmortem serum mast cell tryptase in a fatal anaphylactoid reaction to nonionic radiocontrast medium. J Allergy Clin Immunol 104:237-238";
ref[142] = "Biedermann T, Rueff F, Sander CA, Przybilla B (1999) Mastocytosis associated with severe wasp sting anaphylaxis detected by elevated serum mast cell tryptase levels. Br J Dermatol 141:1110-1112";
ref[143] = "Schwartz LB, Yunginger JW, Miller J, Bokhari R, Dull D (1989) Time course of appearance and disappearance of human mast cell tryptase in the circulation after anaphylaxis. J Clin Invest 83:1551-1555";
ref[144] = "Beyer K, Niggemann B, Schulze S, Wahn U (1994) Serum tryptase and urinary 1-methylhistamine as parameters for monitoring oral food challenges in children. Int Arch Allergy Immunol 104:348-351";
ref[145] = "Venge P, Bystrom J, Carlson M, Hakansson L, Karawacjzyk M, Peterson C, Seveus L, Trulson A (1999) Eosinophil cationic protein (ECP): molecular and biological properties and the use of ECP as a marker of eosinophil activation in disease. Clin Exp Allergy 29:1172-1186";
ref[146] = "Winther L, Moseholm L, Reimert CM, Stahl SP, Kaergaard PL (1999) Basophil histamine release, IgE, eosinophil counts, ECP, and EPX are related to the severity of symptoms in seasonal allergic rhinitis. Allergy 54:436-445";
ref[147] = "Czech W, Krutmann J, Schopf E, Kapp A (1992) Serum eosinophil cationic protein (ECP) is a sensitive measure for disease activity in atopic dermatitis. Br J Dermatol 126:351-355";
ref[148] = "MacGlashan DW, Jr. (1993) Releasability of human basophils: cellular sensitivity and maximal histamine release are independent variables. J Allergy Clin Immunol 91:605-615";
ref[149] = "Kleine-Tebbe J (1993) Basophil histamine release by freshly prepared food extracts. Allergy Proc 14:255-258";
ref[150] = "de Weck AL (1997) Zellulärer Allergen-Stimulierungs-Test (CAST). Allergologie 20:487-502";
ref[151] = "MacGlashan DW, Jr., Peters SP, Warner J, Lichtenstein LM (1986) Characteristics of human basophil sulfidopeptide leukotriene release: releasability defined as the ability of the basophil to respond to dimeric cross-links. J Immunol 136:2231-2239";
ref[152] = "Kepley CL, Youssef L, Andrews RP, Wilson BS, Oliver JM (2000) Multiple defects in Fc epsilon RI signaling in Syk-deficient nonreleaser basophils and IL-3-induced recovery of Syk expression and secretion. J Immunol 165:5913-5920";
ref[153] = "Wedi B (1996) In vitro diagnostic of pseudoallergic reactions - new aspects. ACI Int 8:113-115";
ref[154] = "Cahen YD, Maly FE, Wuthrich B (1997) [Cellular antigen stimulation test (CAST)--applicability in the diagnosis of insect toxin allergies]. Schweiz Med Wochenschr 127:5-11";
ref[155] = "Lebel B, Messaad D, Kvedariene V, Rongier M, Bousquet J, Demoly P (2001) Cysteinyl-leukotriene release test (CAST) in the diagnosis of immediate drug reactions. Allergy 56:688-692";
ref[156] = "Knol EF, Mul FP, Jansen H, Calafat J, Roos D (1991) Monitoring human basophil activation via CD63 monoclonal antibody 435. J Allergy Clin Immunol 88:328-338";
ref[157] = "Saporta M, Kamei S, Persi L, Bousquet J, Arnoux B (2001) Basophil activation during pollen season in patients monosensitized to grass pollens. Allergy 56:442-445";
ref[158] = "Sainte-Laudy J, Sabbah A, Drouet M, Lauret MG, Loiry M (2000) Diagnosis of venom allergy by flow cytometry. Correlation with clinical history, skin tests, specific IgE, histamine and leukotriene C4 release. Clin Exp Allergy 30:1166-1171";
ref[159] = "Honeret-Vautrin DA, Sainte-Laudy J, Kanny G, Fremont S (1999) Human basophil activation measured by CD63 expression and LTC4 release in IgE-mediated food allergy. Ann Allergy Asthma Immunol 82:33-40";
ref[160] = "Berg PA, Daniel PT, Brattig N (1996) Immunologie und Nachweis medikamentöser Allergien. In: Fuchs E, Schulz KH (eds) Manuale Allergologicum IV. Dustri Verlag Dr. Karl Feistle, Deisenhofen, pp 1-13";
ref[161] = "Hertl M, Merk HF (1995) Lymphocyte activation in cutaneous drug reactions. J Invest Dermatol 105:95S-98S";
ref[162] = "Koponen M, Pichler WJ, de Weck AL (1986) T cell reactivity to penicillin: phenotypic analysis of in vitro activated cell subsets. J Allergy Clin Immunol 78:645-652";
ref[163] = "Pichler WJ (1993) Der Lymphozytentransformationstest in der Diagnostik von unerwünschten Arzneimittelreaktionen. In: Merk HF (ed) Allergische und pseudoallergische Arzneimittelreaktionen. pp 119-130";
ref[164] = "Stejskal VD, Olin RG, Forsbeck M (1986) The lymphocyte transformation test for diagnosis of drug-induced occupational allergy. J Allergy Clin Immunol 77:411-426";
ref[165] = "Mauri-Hellweg D, Bettens F, Mauri D, Brander C, Hunziker T, Pichler WJ (1995) Activation of drug-specific CD4+ and CD8+ T cells in individuals allergic to sulfonamides, phenytoin, and carbamazepine. J Immunol 155:462-472";
ref[166] = "May A, Weber A, Gall H, Kaufmann R, Zollner TM (1999) Means of increasing sensitivity of an in vitro diagnostic test for aspirin intolerance. Clin Exp Allergy 29:1402-1411";
ref[167] = "Nyfeler B, Pichler WJ (1997) The lymphocyte transformation test for the diagnosis of drug allergy: sensitivity and specificity. Clin Exp Allergy 27:175-181";
ref[168] = "Kondo N, Agata H, Fukutomi O, Motoyoshi F, Orii T (1990) Lymphocyte responses to food antigens in patients with atopic dermatitis who are sensitive to foods. J Allergy Clin Immunol 86:253-260";
ref[169] = "Werfel T, Ahlers G, Schmidt P, Boeker M, Kapp A (1996) Detection of a kappa-casein-specific lymphocyte response in milk-responsive atopic dermatitis. Clin Exp Allergy 26:1380-1386";
ref[170] = "Werfel T, Ahlers G, Schmidt P, Boeker M, Kapp A, Neumann C (1997) Milk-responsive atopic dermatitis is associated with a casein-specific lymphocyte response in adolescent and adult patients. J Allergy Clin Immunol 99:124-133";
ref[171] = "Wistokat-Wulfing A, Schmidt P, Darsow U, Ring J, Kapp A, Werfel T (1999) Atopy patch test reactions are associated with T lymphocyte-mediated allergen-specific immune responses in atopic dermatitis. Clin Exp Allergy 29:513-521";
ref[172] = "Karplus TE, Ulevitch RJ, Wilson CB (1987) A new method for reduction of endotoxin contamination from protein solutions. J Immunol Methods 105:211-220";
ref[173] = "Rasanen L, Sainio H, Lehto M, Reunala T (1991) Lymphocyte proliferation test as a diagnostic aid in chromium contact sensitivity. Contact Dermatitis 25:25-29";
ref[174] = "Rasanen L, Tuomi ML (1992) Diagnostic value of the lymphocyte proliferation test in nickel contact allergy and provocation in occupational coin dermatitis. Contact Dermatitis 27:250-254";
ref[175] = "Werfel T, Hentschel M, Kapp A, Renz H (1997) Dichotomy of blood- and skin-derived IL-4-producing allergen-specific T cells and restricted V beta repertoire in nickel-mediated contact dermatitis. J Immunol 158:2500-2505";
ref[176] = "Schreiber J, Zissel G, Greinert U, Galle J, Schulz KH, Schlaak M, Muller-Quernheim J (1999) [Diagnosis of chronic berylliosis]. Pneumologie 53:193-198";
ref[177] = "Cederbrant K, Hultman P, Marcusson JA, Tibbling L (1997) In vitro lymphocyte proliferation as compared to patch test using gold, palladium and nickel. Int Arch Allergy Immunol 112:212-217";
ref[178] = "Merk HF (1988) In-vitro-Diagnostik bei Arzneimittel-Allergien. Allergologie 11:57-59";
ref[179] = "Roujeau JC, Albengres E, Moritz S, Piacentino A, Cuny M, Revuz J, Touraine R (1985) Lymphocyte transformation test in drug-induced toxic epidermal necrolysis. Int Arch Allergy Appl Immunol 78:22-24";
ref[180] = "Merk HF (1989) Arzneimittelallergie: Einfluss des Fremdstoff-Metabolismus. Allergologie 12:171-173";
ref[181] = "Bodycote J, Wolff S (1986) Metabolic breakdown of [3H]thymidine and the inability to measure human lymphocyte proliferation by incorporation of radioactivity. Proc Natl Acad Sci U S A 83:4749-4753";
ref[182] = "Wells AD, Gudmundsdottir H, Turka LA (1997) Following the fate of individual T cells throughout activation and clonal expansion. Signals from T cell receptor and CD28 differentially regulate the induction and duration of a proliferative response. J Clin Invest 100:3173-3183";
ref[183] = "Boeker M, Werfel T (1994) In vitro Untersuchungen von Antigen- und Allergen-spezifisch aktivierten mononukleären Zellen. Allergologie 17:374-379";
ref[184] = "Werfel T, Boeker M, Kapp A (1997) Rapid expression of the CD69 antigen on T cells and natural killer cells upon antigenic stimulation of peripheral blood mononuclear cell suspensions. Allergy 52:465-469";
ref[185] = "Abernathy-Carver KJ, Sampson HA, Picker LJ, Leung DY (1995) Milk-induced eczema is associated with the expansion of T cells expressing cutaneous lymphocyte antigen. J Clin Invest 95:913-918";
ref[186] = "Reekers R, Busche M, Wittmann M, Kapp A, Werfel T (1999) Birch pollen-related foods trigger atopic dermatitis in patients with specific cutaneous T-cell responses to birch pollen antigens. J Allergy Clin Immunol 104:466-472";
ref[187] = "Eigenmann PA, Tropia L, Hauser C (1999) The mucosal adhesion receptor alpha4beta7 integrin is selectively increased in lymphocytes stimulated with beta-lactoglobulin in children allergic to cow's milk. J Allergy Clin Immunol 103:931-936";
ref[188] = "Klimek L, Malling HJ (1999) Die spezifische Immuntherapie (Hyposensibilisierung) bei allergischer Rhinokonjunktivitis. Metaanalyse zu Wirksamkeit und Nebenwirkungen. HNO 47:602-610";
ref[189] = "Klimek L (2000) Die allergenspezifische Immuntherapie (Hyposensibilisierung) Teil 1: Grundlagen und subkutane Applikation. HNO 48:116-122";
ref[190] = "Fuchs T, Klimek L (2000) Die allergenspezifische Immuntherapie (Hyposensibilisierung) Teil 2. HNO 48:158-164";
ref[191] = "Greiner W, Graf von der Schulenberg JM, Gillissen A (2002) Kosten und Nutzen der Hyposensibilisierung bei allergischem Asthma und Rhinitis. Gesundh ökon Qual manag 7:179-186";
ref[192] = "Schadlich PK, Brecht JG (2000) Economic evaluation of specific immunotherapy versus symptomatic treatment of allergic rhinitis in Germany. Pharmacoeconomics 17:37-52";
ref[193] = "Moller C, Dreborg S, Ferdousi HA, Halken S, Host A, Jacobsen L, Koivikko A, Koller DY, Niggemann B, Norberg LA, Urbanek R, Valovirta E, Wahn U (2002) Pollen immunotherapy reduces the development of asthma in children with seasonal rhinoconjunctivitis (the PAT-study). J Allergy Clin Immunol 109:251-256";
ref[194] = "Jacobsen L, Niggemann B, Dreborg S, Ferdousi HA, Halken S, Host A, Koivikko A, Norberg LA, Valovirta E, Wahn U, Moller C (2007) Specific immunotherapy has long-term preventive effect of seasonal and perennial asthma: 10-year follow-up on the PAT study. Allergy 62:943-948";
ref[195] = "Des RA, Paradis L, Menardo JL, Bouges S, Daures JP, Bousquet J (1997) Immunotherapy with a standardized Dermatophagoides pteronyssinus extract. VI. Specific immunotherapy prevents the onset of new sensitizations in children. J Allergy Clin Immunol 99:450-453";
ref[196] = "Purello-D'Ambrosio F, Gangemi S, Merendino RA, Isola S, Puccinelli P, Parmiani S, Ricciardi L (2001) Prevention of new sensitizations in monosensitized subjects submitted to specific immunotherapy or not. A retrospective study. Clin Exp Allergy 31:1295-1302";
ref[197] = "Coombs RR, Gell PGH (1963) The classification of allergic reactions underlying disease. p 317";
ref[198] = "Klimek L (2007) Labordiagnostik allergischer Erkrankungen. CME Praktische Fortbildung Hals-Nasen-Ohrenheilkunde 1:";
ref[199] = "Herstellerangaben";
ref[200] = "Allergy Principles und Practice, Fourth Edition, E. Middleton, Jr. et al. (eds), Mosby St. Louis, 1993";
ref[201] = "Johannes Ring, Angewandte Allergologie, 2. Auflage, MMV Medizin Verlag München, 1991 ";
ref[202] = "Allen P. Kaplan, Allergy, Churchill Livingstone New York 1985 ";
ref[203] = "Arbeitskreis „Bronchiale u. nasale Provokationstests“ der DGAI, Richtlinien für die Durchführung von nasalen Provokationstests mit Allergenen bei Erkrankungen der oberen Luftwege, Allergologie 13:53-55 (1990)";
ref[204] = "Pakes, G. E., Brogden, R. N., Heel, R. D., Speight, T. M., Avery, G. S. Flunisolide: a review of its pharmacological properties and therapeutic efficacy in rhinitis. Drugs 19 (1980) 397 - 411";
ref[205] = "Swiebert, L. A., Beck, L. A., Stellato, C., et al. Glucocorticosteroid inhibition of cytokine production: Relevance to antiallergic actions. J Allergy Clin Immunol 97 (1996) 143 - 152";
ref[206] = "Barnes, P. J., Adock, I. Anti-inflammatory actions of steroids: molecular mechanisms. Trends Pharmacol Sci 14 (1993) 436 - 441";
ref[207] = "Scheinmann, R. I., Cogswell, P. C., Lofquist, A. K., Baldwin, A. S. Role of transcriptional activation of I kappa B alpha in mediation of immunosuppression by glucocorticoids. Science 270 (1995) 283 - 286";
ref[208] = "Auphan, N., DiDonato, J. A., Rossette, C., Helmberg, A., Karin, M. Immunosuppression by glucocorticoids: inhibition of NK-?B activity through induction of I?B synthesis. Science 270 (1995) 286 - ";
ref[209] = "Rudack, C., Bachert, C. Glucocorticosteroids rapidly inhibit allergen-induced expression of E-selectin in vitro in a mucosal model of allergic rhinitis. Allergy (1999) ";
ref[210] = "Bascom, R., Wachs, M., Naclerio, R. M., Pipkorn, U., Galli, S., Lichtenstein, L. M. Basophil influx occurs after nasal antigen challenge: effects of topical corticosteroid pretreatment. J Allergy Clin Immunol 81 (1988) 580 - 589";
ref[211] = "Naclerio, R. M. Inflammation in allergic rhinitis. Res Clin Forums 14 (1992) 49 - 55";
ref[212] = "Pederson, S., O'Byrne, P. A comparison of the efficacy and safety of inhaled corticosteroids in asthma. Allergy 52 (1997) 1 - 34";
ref[213] = "Kay, A. B. Asthma and inflammation. J Allergy Clin Immunol 87 (1991) 893 - 910";
ref[214] = "Rak, S., Jacobson, M. R., Sudderick, R. M., Masuyama, K., et al. Influence of prolonged treatment with topical corticosteroid (fluticasone propionate) on early and late phase nasal responses and cellular infiltration in the nasal mucosa after allergen challenge. Clin Exp Allergy 24 (1994) 930 - 939";
ref[215] = "Mygind, N., Lund, V. Topical corticosteroid therapy of rhinitis. Clin Immunother 5 (1996) 122 - 136";
ref[216] = "Baroody, F. M., Rouadi, P., Driscoll, P. V., Bochner, B. S., Naclerio, R. M. Intranasal beclomethasone reduces allergen-induced symptoms and superficial mucosal eosinophilia without affecting submucosal inflammation. Am J Respir Crit Care Med 157 (1998) 899 - 906";
ref[217] = "Pipkorn, U. Effect of topical glucocorticoid treatment on nasal mucosa mast cells in allergic rhinitis. Allergy 38 (1983) 125 - 129";
ref[218] = "Cox, G., Ohtoshi, T., Vancheri, C., Denburg, J. A., Dolovich, J., Gauldie, J., Jordana, M. Promotion of eosinophil survival by human bronchial epithelial cells and its modulation by steroids. Am J Respir Cell Mol Biol 4 (1991) 525 - 531";
ref[219] = "Mattoli, S., Vittori, E., Marini, M. Corticosteroids downregulate the increased expression of GM-CSF, Il6 and Il8 in brochial epithelium of asthmatic patients (abstract). J Allergy Clin Immunol 89 (1992) 164 - 164";
ref[220] = "Baker, C., Altman, L. C. The effect of dexamethasone and cromolyn sodium on intercellular adhesion molecules-1 expression on human nasal epithelial cells (abstract). J Allergy Clin Immunol 89 (1992) 212 - 212";
ref[221] = "Knani, N., Denburg, J. A., Evans, S., Conway, M., Jordana, M., Dolovich, J. Depletion of T lymphocytes in nasal polyps treated by topical steroid (abstract). J Allergy Clin Immunol 89 (1992) 221 - 221";
ref[222] = "Fattal-German, M., Le Roy Ladurie, F., Cerrina, J., Lecerf, F., Berrih-Aknin, S. Expression and modulation of ICAM-1, TNF-alpha and RANTES in human alveolar macrophages from lung-transplant recipients in vitro. Transpl Immunol 6 (1998) 183 - 192";
ref[223] = "Bentley, A. M., Cumberworth, V., Varney, V. A.: Studies during the pollen season in understanding allergic rhinitis. In: Advances in allergology and clinical immunology.; Godard, P., Bousquet, J., Michel, F. B.; S.457 - 464. Carnforth 1992";
ref[224] = "Stellato, C., Beck, L. A., Gorgone, G. A., et al. Expression of the chemokine RANTES by a human bronchial epithelial cell line. J Immunol 155 (1995) 410 - 418";
ref[225] = "Wang, J. H., Davalia, J. L., Xia, C., et al. Expression of RANTES by human bronchial epithelial cells in vitro and in vivo and the effect of corticosteroids. Am J Respir Cell Biol 14 (1996) 27 - 35";
ref[226] = "Weido, A. J., Reece, L. M., Alam, R., et al. Intranasal fluticasone proprionate inhibits recovery of chemokines and other cytokines in nasal secretions in allergen-induced rhinitis. Ann Allergy Asthma Immunol 77 (1996) 407 - 415";
ref[227] = "Meltzer, E. O. Nasal cytological changes following pharmacological intervention. Allergy 50 (1995) 15 - 20";
ref[228] = "Roca-Ferrer, J., Mullol, J., Lopez, E., Xaubet, A., Pujols, L., Fernandez, J. C., Picado, C. Effect of topical anti-inflammatory drugs on epithelial cell-induced eosinophile survival and GM-CSF secretion. Eur Respir J 10 (1997) 1489 - 1495";
ref[229] = "Naclerio, R. M. The pathophysiology of allergic rhinitis: impact of therapeutic intervention. J Allergy Clin Immunol 82 (1988) 927 - 934";
ref[230] = "Naclerio, R. M., Proud, D., Togias, A. G. Inflammatory mediators in late antigen-induced rhinitis. N Engl J Med 313 (1985) 65 - 70";
ref[231] = "Freeland, H., Pipkorn, U., Proud, D., Naclerio, R. M., Lichtenstein, L. M., Peters, S. P. Leukotriene B4 as a mediator of early and late reactions to antigen in humans. The effect of systemic glucocorticoid treatment in vivo. J Allergy Clin Immunol 83 (1989) 634 - 642";
ref[232] = "Cronstein, B. N., Kimmel, S. C., Levin, R. I., Martiniuk, F., Weissmann, G. A mechanism for the antiinflammatory effects of corticosteroids: The glucocorticoid receptor regulates leukocyte adhesion to endothelial cells and expression of endothelial-leucocyte adhesion molecule a and intercellular adhesion molecule 1. Proc Natl Acad Sci USA 89 (1992) 9991 - 9995";
ref[233] = "van den Stolpe, A., Caldenhoven, E., Raaijmakers, J. A. M., et al. Glucocorticoid-mediated repression of Intercellular Adhesion Molecule-1 expression in human monocytic and bronchial epithelial cell lines. Am J Respir Cell Mol Biol 8 (1993) 340 - 347";
ref[234] = "Andersson, K. E., Bende, M. Adrenoceptors in the control of human nasal mucosal blood flow. Ann Otol Laryngol 93 (1984) 179 - 182";
ref[235] = "Pipkorn, U. Budesonide and nasal allergen challenge testing in man. Allergy 37 (1982) 129 - 134";
ref[236] = "Bende, M., Lindquist, N., Pipkorn, U. The effect of a topical steroid, budesonide, on nasal mucosal blood flow as measured with 133Xe wash-out technique. Allergy 38 (1983) 461 - 464";
ref[237] = "Baumgarten, C. R., Togias, A., Naclerio, R. M., Norman, P. S., Lichtenstein, L. M., Proud, D. Kininogens are generated following nasal challenge with allergen in allergic individuals but not in non-allergic individuals. J Clin Invest 76 (1985) 191 - 197";
ref[238] = "Proud, D., Togias, A., Naclerio, R. M., Crush, S., Norman, P. S., Lichtenstein, L. M. Kinins are generated in vivo following nasal airway challenge of allergic individuals with allergen. J Clin Invest 72 (1983) 1678 - 1685";
ref[239] = "Pipkorn, U., Proud, D., Lichtenstein, L. M. Effects of short-term systemic glucocorticoid treatment on human nasal mediator release after antigen challenge. J Clin Invest 80 (1987) 957 - 957";
ref[240] = "Pipkorn, U., Proud, D., Lichtenstein, L. M., Kagey-Sobotka, A., Norman, P. S., Naclerio, R. M. Inhibition of mediator release in allergic rhinitis by pretreatment with topical glucocorticosteroids. N Engl J Med 316 (1987) 1506 - 1510";
ref[241] = "Sorensen, H., Mygind, N., Pedersen, C. B., Prytz, S. Long term treatment of nasal polyps with beclomethasone dipropionate aerosol. III.Acta Otolaryngol (Stockh.) 82 (1976) 260 - 262";
ref[242] = "Brogden, R. N., Heel, R. C., Speight, T. M., Avery, G. S. Beclomethasone dipropionate. A reappraisal of its pharmacodynamic properties and therapeutic efficacy after a decade of use in asthma and rhinitis. Drugs 28 (1984) 99 - 126";
ref[243] = "Clissold, S. P.: Rhinitis. In: Budesonide: clinical experience in asthma and rhinitis.; Barnes, P. J., Mygind, N.; S.51 - 64. Manchester 1988";
ref[244] = "Naclerio, R. M.: Intranasal steroids. In: Allergic and non-allergic rhinitis: clinical aspects.; Mygind, N., Naclerio, R. M.; S.114 - 122. Copenhagen 1993";
ref[245] = "Pipkorn, U., Norman, P. S., Middleton, E. Jr.: Topical steroids. In: Allergic and vasomotor rhinitis: clinical aspects.; Mygind, N., Weeke, B.; S.165 - 179. Copenhagen 1985";
ref[246] = "Canonica GW et al., Allergy 2007; 62 (85): 17-25";
ref[247] = "Adelphi Market Research, GSK-interne Daten";
ref[248] = "White P. et al., Clin Exp Allergy 1998; 28: 266-270";
ref[249] = "Valotis A. und Högger P., Respir Res 2007; 8: 54";
ref[250] = "Salter M et al., Am J Physiol Lung Cell Mol Physiol 2007: 293: L660-L667";
ref[251] = "Bryson H.M. et al., Drugs 1992; 43: 760";
ref[252] = "Daley-Yates P.T. et al., Br J Clin Pharmacol 2001; 51: 103-105";
ref[253] = "Daley-Yates P.T. et al., Eur J Clin Pharmacol 2004; 60: 265-268";
ref[254] = "Fokkens W.J. et al., Allergy 2007; 62: 1078-1084";
ref[255] = "Kaiser H.B. et al., J Allergy Clin Immunol 2007; 119 (6): 1430-1437";
ref[256] = "Naclerio R et al., Otolaryngology-Head and Neck Surgery 2008; 138: 129-139";
ref[257] = "Rosenblut A et al., Allergy 2007; 62 (Suppl. 83): 227";
ref[258] = "GlaxoSmithKline, FFR100012. ";
ref[259] = "Berger W.E. et al., Expert Opin Drug Deliv 2007; 4 (6): 689-701";
ref[260] = "Bousquet, J., Chanal, I., Alquie, M. C., Charpin, D., Didier, A., Gemouty, J., Greillier, P., Ickovic, M. H., Maria, Y., Montone, F., et al. Prevention of pollen rhinitis. Comparison of fluticasone propionate aqueous nasal spray versus disodium cromoglycate nasal spray. Allergy 48 (1993) 327 - 333";
ref[261] = "Welsh, P. W., Stricker, W. E., Chu, C. P., Naessens, J. M., Reese, M. E., Reed, C. E., Marcoux, J. P. Efficacy of beclomethasone nasal solution, flunisolide and cromolyn in relieving symptoms of ragweed allergy. Mayo Clin Proc 62 (1987) 125 - 134";
ref[262] = "Beswick, K. B., Kenyon, G. S., Cherry, J. R. A comparative study of beclomethasone dipropionate aqueous nasal spray with terfenadine tablets in seasonal allergic rhinitis. Curr Med Res Opin 9 (1985) 560 - 567";
ref[263] = "Bunnag, C., Jareoncharsri, P., Wong, E. C. K. A double-blind comparison of nasal budesonide and oral astemizole for treatment of perennial rhinitis. Allergy 47 (1992) 313 - 317";
ref[264] = "Frolund, L. Efficacy of oral antihistamine, loratadine, as compared with nasal steroid spray, beclomethasone dipropionate, in seasonal allergic rhinitis. Clin Otolaryngol 16 (1992) 527 - 531";
ref[265] = "Harding, S. M., Heath, S. Intranasal steroid aerosol in perennial rhinitis: comparison with an antihistamine compound. Clin Allergy 6 (1976) 369 - 372";
ref[266] = "Juniper, E. F., Kline, P. A., Hargreave, F. E., Dolovich, J. Comparison of beclomethasone dipropionate aqueous spray, astemizole, and the combination in the prophylactic treatment of ragweed-induced rhinoconjunctivitis. J Allergy Clin Immunol 83 (1989) 627 - 633";
ref[267] = "Munch, E., Soborg, M., Norreslet, T. T., Mygind, N. A comparative study of dexchlopheniramine maleate sustained tablets and budesonide nasal spray in seasonal allergic rhinitis. Allergy 38 (1983) 517 - 524";
ref[268] = "Salomonsson, P., Gottberg, L., Heilborn, H., Norrlind, K., Pegelow, K. O. Efficacy of an oral antihistamine, astemizole, as compared to a nasal steroid spray in hay fever. Allergy 43 (1988) 214 - 218";
ref[269] = "Weiner, J. M., Abramson, M. J., Puy, R. M. Intranasal corticosteroids versus oral H1 receptor antagonists in allergic rhinitis: systematic review of randomised controlled trials. BMJ 317 (1998) 1624 - 1629";
ref[270] = "Mygind, N. Local effect of intranasal beclomethasone dipropionate aerosol in hay fever. BMJ 4 (1973) 464 - 466";
ref[271] = "Pipkorn, U., Rundcrantz, H., Lindquist, N. Budesonide - a new nasal steroid. Rhinology 18 (1980) 171 - 175";
ref[272] = "Turkeltaub, P. C., Norman, P. S., Crepea, S. Treatment of ragweed hay fever with an intranasal spray containing flunisolide: a new synthetic corticosteroid. J Allergy Clin Immunol 58 (1976) 597 - 606";
ref[273] = "Cockcroft, D. W., MacCormack, D. W., Newhouse, M. T., Hargreave, F. E. Beclomethasone dipropionate in allergic rhinitis. Can Med Assoc J 115 (1976) 523 - 526";
ref[274] = "Henriksen, J., Wenzel, A. Effect of an intranasally administered corticosteroid (budesonide) on nasal obstruction, mouth breathing, and asthma. Am Rev Resp Dis 130 (1984) 1014 - 1018";
ref[275] = "Reed, C. E., Marcoux, J. P., Welsh, P. W. Effects of topical nasal treatment on asthma. J Allergy Clin Immunol 81 (1988) 1042 - 1047";
ref[276] = "Tarlo, S. M., Cockcroft, D. W., Dolovich, J., Hargreave, F. E. Beclomethasone dipropionate aerosol in perennial rhinitis. J Allergy Clin Immunol 59 (1977) 232 - 236";
ref[277] = "Balle, V. H., Pedersen, U., Engby, B. Allergic perennial and nonallergic vasomotor rhinitis treated with budesonide nasal spray. Rhinology 18 (1980) 135 - 142";
ref[278] = "Hansen, I., Mygind, N. Local effect of intranasal beclomethasone dipropionate aerosol in perennial rhinitis. Acta Allerg (Kbh) 29 (1974) 281 - 287";
ref[279] = "Lindquist, N., Balle, V., Karma, P., Karja, J., Lindstrom, D., Makinen, J., Pukander, J., Ruoppi, P., Suonpaa, J., Ostlund, W., et al. Long term safety and efficacy of budesonide nasal aerosol in perennial rhinitis - a 12 month multicenter study. Allergy 41 (1986) 179 - 186";
ref[280] = "Löfkvist, T., Svensson, G. Treatment of vasomotor rhinitis with beclomethasone dipropionate. Acta Allerg (Kbh) 31 (1976) 227 - 238";
ref[281] = "Pipkorn, U., Pukander, J., Suonpaa, J., Makinen, J., Lindquist, N. Long-term safety of budesonide nasal aerosol - a 5.5 year follow up study. Clin Allergy 18 (1988) 253 - 259";
ref[282] = "Small, P., Black, M., Frenkiel, S. Effect of treatment with beclomethasone dipropionate in subpopulations of perennial rhinitis patients. J Allergy Clin Immunol 70 (1982) 78 - 82";
ref[283] = "Heppt, W. Zytologie der Nasenschleimhaut(1995) ";
ref[284] = "Whelan, C. F. A. Problems in the examination of nasal smears in allergic rhinitis. J Laryngol Otol 84 (1980) 399 – 405";
ref[285] = "Deuschl, H., Drettner, B. Nasal polyps treated with beclomethasone nasal aerosol. Rhinology 15 (1977) 17 - 23";
ref[286] = "Holopainen, E., Grahne, B., Malmberg, H., Makinen, J., Lindquist, N. Budesonide in the treatment of nasal polyposis. Eur J Respir Dis 63 (1982) 221 - 228";
ref[287] = "Mygind, N., Pedersen, C. B., Prytz, S., Sorensen, H. Treatment of nasal polyps with intranasal beclomethasone dipropionate aerosol. Clin Allergy 5 (1975) 159 - 164";
ref[288] = "Drettner, B., Ebbesen, A., Nilsson, M. Prophylactic treatment with flunisolide after polypectomy. Rhinology 20 (1982) 149 - 158";
ref[289] = "Toft, A., Wihl, J. A., Toxman, J., Mygind, N. Double-blind comparison between beclomethasone dipropionate as aerosol and as powder in patients with nasal polyposis. Clin Allergy 12 (1982) 391 - 401";
ref[290] = "Soderberg-Warner, M. L. Nasal septal perforation associated with topical corticosteroid therapy. J Pediatr 105 (1984) 840 - 841";
ref[291] = "Brown, H. M., Storey, G., Jackson, F. A. Beclomethasone dipropionate aerosol in treatment of perennial and seasonal rhinitis: a review of five years experience. Br j clin pharmacol 4 (1977) 283 - 286";
ref[292] = "Mygind, N., Sorensen, H., Pedersen, C. B. The nasal mucosa during long-term treatment with beclomethasone dipropionate aerosol. A light- and scanning-electron-microscopic study of nasal polyps. Acta Otolaryngol (Stockh) 85 (1978) 437 - 443";
ref[293] = "Sarnstrand, B., Jeppsson, A., Malmstrom, A., Brattsand, R.: Effect of glucocorticosteroids on hyaluronic acid synthesis in vitro in human fibroblast-like cells from lung and skin. In: Glucocorticosteroids, inflammation and bronchial hyperreactivity; Hogg, J. C., Ellul-Micalef, R., Brattsand, R.; S.157 - 166. Amsterdam 1985";
ref[294] = "Cheng, C. C., Baroody, F. M., Reed, K. C., Cook, C., Rogenes, P., Sengupta, E., Togias, A. G., Naclerio, R. M. Effects of one year treatment with fluticasone propionate aqueous nasal spray (FPANS) and terfenadine (TER) on the nasal mucosa: I. A safety study using electron and light microscopy. J Allergy Clin Immunol 99 (1997) 2013 – 2013";
ref[295] = "Minshall, E., Ghaffar, O., Cameron, L., O´Brien, F., Quinn, H. et al. Otolaryngol Head and Neck Surgery (in press)";
ref[296] = "Frauenfelder, F. T., Myer, S. M. Posterior subcapsular cataracts associated with nasal or inhalation corticosteroids. Am J Ophthalmol 109 (1990) 489 - 490";
ref[297] = "Harding, S. M. The human pharmacology of fluticasone propionate. Respir Med 84 (1990) 25 - 29";
ref[298] = "Rachelefsky G.S., Chervinsky P., Meltzer E.O., Morris R.M., Seltzer J.M., Skoner, D. P., Storms W.W. An evaluation of the effects of beclomethasone diproprionate on long-term growth in children. J Allergy Clin Immunol 101 (1998) 236 -";
ref[299] = "van As, A., Bronsky, E., Grossman, J., Meltzer, E. O., Ratner, P., Reed, C. Dose tolerance study of fluticasone propionate aqueous nasal spray in patients with seasonal allergic rhinitis. Ann Allergy 67 (1991) 156 - 162";
ref[300] = "Schenkel, E.J. , Skoner D.P., Bronsky, E.A., Miller, S.D. et al. Absence of Growth Retardation in children with perennial allergic rhinitis after one year of treatment with mometasone furoate aqueous nasal spray 105 (2000) 1 - 7";
ref[301] = "Kaiser H.B. et al., J Allergy Clin Immunol 2007; 119 (6): 1430-1437.";
ref[302] = "Martin B.G. et al., Allergy Asthma Proc 2007; 28: 216-225. ";
ref[303] = "Rosenblut A et al., Allergy 2007; 62 (Suppl. 83): 227. ";
ref[304] = "Meltzer E. et al., Allergy 2007; 62 (Suppl. 83): 130. ";
ref[305] = "Maspero J. et al., Allergy 2007; 62 (Suppl. 83): 381. ";
ref[306] = "Ratner P. et al., Allergy 2007; 62 (Suppl. 83): 130. ";
ref[307] = "Patel P. et al., Allergy 2007; 62 (Suppl. 83): 226.";
ref[308] = "Berger W. E. et al. – Expert Opin Drug Deliv 2007, 4 (6): 689-701";
ref[309] = "Stanford R. Et al., J Allergy Clin Immunol 2007, 119 (Suppl. S) : S228";
ref[310] = "Okuda, M., Othsuka, H. Basophilic cells in allergic nasal secretions. Arch Otorhinolaryngol 214 (1977) 283 - 289";
ref[311] = "Okuda, M., Othsuka, H., Sakaguchi, K., Ohnishi, M., Okubo, K. Effect of anti-allergic treatment on nasal surface basophilic metachromatic cells in allergic rhinitis. Allergy Proc 10 (1989) 23 - 26";
ref[312] = "Bachert, C. Wirksamkeit und Verträglichkeit von Fluticasonpropionat bei der Behandlung der allergischen Rhinitis. Allergologie 21 (1998) 150 - 165";
ref[313] = "Findlay, S., Huber, F., Garcia, J., Huang, L. Efficacy of once-a-day intranasal administration of triamcinolone acetonide in patients with seasonal allergic rhinitis. Ann Allergy 68 (1992) 228 - 232";
ref[314] = "Lund, V. Fluticasone propionate - a new and effective treatment for both allergic and non-allergic perennial rhinitis (abstract). Allergy 12 (1999) 347 - 347";
ref[315] = "Sahay, J. N., Chatterjee, S. S., Engler, C. A comparative trial of flunisolide and beclomethasone dipropionate in the treatment of perennial allergic rhinitis. Clin Allergy 10 (1980) 65 - 70";
ref[316] = "Storms, W., Bronsky, E., Findley, S., Pearlman, D., Rosenberg, S., Shapiro, G., Southern, L., Tinkelman, D., Weakley, S., Welch, M., et al. Once daily triamcinolone acetonide nasal spray is effective for the treatment of perennial allergic rhinitis. Ann Allergy 66 (1991) 329 - 334";
ref[317] = "Welch, M. J., Bronsky, E. A., Grossman, J., Shapiro, G. G., Tinkelman, D. G., Garcia, J. D., Gillen, M. S. Clinical evaluation of triamcinolone acetonide nasal aerosol in children with perennial allergic rhinitis. Ann Allergy 67 (1991) 493 - 498";
ref[318] = "Berger WE, Godfrey JW, Slater AL. Intranasal corticosteroids: the development of a drug delivery device for fluticasone furoate as a potential step toward improved compliance. Exper Opin Drug Deliv. 2007; 4(6): S. 689-701.";
ref[319] = "Berger W, Godfrey JW, Grant AC et al. Fluticasone furoate (FF) nasal spray - development of a next-generation delivery system for allergic rhinitis. J Allergy Clin Immunol 2007; 119 (1 Suppl): S.231.";
ref[320] = "Godfrey JW, Grant AC, Slater AL. Fluticasone furoate (FF) nasal spray - ergonomic considerations for a next generation delivery system. J Allergy Clin Immunol 2007; 119 (1 Suppl): S. 230.";
ref[321] = "Salter M, Biggadike K, Matthews JL et al. Pharmacological properties of the enhanced-affinity glucocorticoid fluticasone furoate in vito and in an in vivo model of repiratory inflammatory disease. Am J Physiol Lung Cell Mol Physiol 2007; 293: 660-667.";
ref[322] = "Berger, WE, Godfrey JW, Slater AL. Intranasal corticosterioids: the development of a drug delivery device for fluticasone furoate as a potential step toward improved compliance. Exper Opin. Drug Deliv. 2007; 4(6): 689-701";
ref[323] = "Berger, WE, Godfrey JW, Grant AC et al. Fluticasone furoate (FF) nasal spray - development of a next-generation delivery system for a allergic rhinitis. J Allergy Clin Immunol 2007; 119(1 Suppl): 231.";
ref[324] = "Nathan R, Berger W, Yang W et al. Once-daily fluticasone furoate nasal spray relievesnasal symptoms in adults and adolescents with perennial allergic rhinitis.Submitted to journal.";
ref[325] = "Ratner P, Andrews C, van Bavel J et al. Once-daily fluticasone furoate* nasal spray (FF)effectively treats ocular symptoms of seasonal allergic rhinitis (SAR) caused by mountaincedar pollen.*USAN approved name. J Allergy Clin Immunol 2007; 119(Supp 1): S231.";
ref[326] = "Canonica GW, Bousquet J, Mullol J et al. A survey of the burden of allergicrhinitis in Europe. Allergy 2007; 62(85): 17-25.";
ref[327] = "van Bavel J, Toler T, Ellsworth A et al. Once-daily fluticasone furoate* nasalspray (FFNS) improves quality of life (QoL) in subjects with seasonal allergicrhinitis (SAR) during the mountain cedar pollen season.*USAN approvedname. J Allergy Clin Immunol 2007; 119(Supp 1): S230.";
ref[328] = " Patel D, Ratner P, Clements D et al. Lack of effect on adult and adolescent HPA axisfunction with use of fluticasone furoate nasal spray. Submitted to journal.";
ref[329] = "Rosenblut A, Bardin PG, Muller B et al. Long-term safety of fluticasone furoate nasalspray in adults and adolescents with perennial allergic rhinitis. Allergy 2007; 62: 1071-1077.";
ref[330] = "Fokkens WJ, Jogi R, Reinartz S et al. Once daily fluticasone furoat nasal spray is effective in seasonal allergic rhinitis caused by grass pollen. Allergy 2007 62: 1078-1084";
ref[331] = "Martun BG, Ratner PH, Hampel FC et al. Optimal dose selection of fluticasone furoate nasalspray for the treatment of seasonal allergic rhinitis in adults and adolescents. Allergy Asthma Proc 2007; 28(2): 216-225";
ref[332] = "Kaiser HB, Naclerio RM, Given J et al. Fluticasone furoate nasal spray: a single treatment option for the symptoms of seasonal allergic rhinitis. J Allergy Clin Immunol 2007; 119 (6): 1430-1437";
ref[333] = "Veramyst (fluticasone furoate) label information; http:/www.fda.gov/cder/foi/label/2007/022051lbl.pdf Last accessed 16/11/07";
ref[334] = "Allen A, Down G, Newland A et al. Absolute bioavailability of fluticasone furoate nasal spray in healthy subjects. Clin Ther 2007; 29(7): 1415-1420";
ref[335] = "Avamys SPC";
ref[336] = "Mandl M, Nolop K, Lutsky B. Comparison of once daily mometasone furoate (Nasonex) and fluticasone proprionate aqueous nasal sprays for the treatment of perennial rhinitis. Ann Allergy Asthma Immunol 1997;79: 370-345";
ref[337] = " Drouin M. Yang W, Bertrand B et al. Once daily mometasone furoate aqueous nasal spray is as effective as twice daily beclomethasone diproprionate for treating perennial allergic rhinitis patients. Ann Allergy Asthma Immunol 1996; 77: 153-160";
ref[338] = "Koepke JW, Beaucher WN, Kobashi RH et al. Long-term safety and efficacy of triamcinolone acetonide aqueous nasal spray for the treatment of perennial rhinitis. Allergy Asthma Proc 1997; 18(1): 33-7";